Janssen Pharmaceutica, N.V. v. Kappos
844 F. Supp. 2d 707
E.D. Va.2012Background
- Janssen seeks a 98-day patent term adjustment (PTA) for the '356 patent and sues the USPTO and Director Kappos seeking judicial review.
- Defendants move to dismiss, arguing the action belongs in DC federal court under 35 U.S.C. § 154(b)(4)(A) and may be time-barred.
- Statutory framework: PTA adjustments under 154(b); pre-issuance (A and B delays) and Director-determined PTA; reconsideration procedures; post-issuance review possible via APA with limits.
- The '356 patent issued June 22, 2010 with PTA of 1009 days; initial PTA based on April 9, 2007 action, but July 16, 2007 action could yield more delay.
- Janssen pursued Rule 181 petitions and later challenged Decisions I–III through agency review, culminating in Decision III labeling a final agency action.
- At filing (Sept. 9, 2011), venue was exclusive to DC under § 154(b)(4)(A); the court transfers the action to DC, noting later Amended venue rules under the AIA apply only to actions commenced after Sept. 16, 2011.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether § 154(b)(4)(A) controls venue and timing for PTA review | Janssen argues APA review applies; § 154(b)(4)(A) not exclusive post-issuance. | § 154(b)(4)(A) provides exclusive forum and 180-day limit for PTA challenges, regardless of pre/post issuance. | § 154(b)(4)(A) applies; exclusive DC venue and 180-day limit govern PTA challenges. |
| Whether APA review can circumvent § 154(b)(4)(A) restrictions | APA review permits broader post-issuance challenges outside § 154(b)(4)(A). | Statutory scheme preempts generic APA remedies; penalties and venue remain tailored in § 154(b)(4)(A). | APA does not override § 154(b)(4)(A); two statutes coexist with the patent statute’s restrictions controlling venue and timing. |
| Whether the case should be transferred rather than dismissed | Transfer to DC is appropriate in the interest of justice. | Suit filed in wrong venue; transfer to DC is proper under 28 U.S.C. § 1631. | Action is transferred to the DC district court; appropriate under § 1631 and § 154(b)(4)(A). |
| Whether tolling or Locomotive Engineers applies to § 154(b)(4)(A) timing | Timeliness tolled by a timely reconsideration request pending before the agency. | Locomotive Engineers tolling does not apply to § 154(b)(4)(A) actions; timing starts on patent issuance. | Tolling may affect timeliness in transfer context under DC authority; Bristol-Myers guidance cited as basis for transfer. |
Key Cases Cited
- Wyeth v. Kappos, 591 F.3d 1364 (Fed. Cir. 2010) (summaries PTA delay types and framework)
- Block v. North Dakota, 461 U.S. 273 (U.S. 1983) (preemption of general remedies by specific statutory schemes)
- EC Term of Years Trust v. United States, 550 U.S. 429 (U.S. 2007) (preemption and exclusive remedies when general remedy would extend limitations)
- Franchi v. Manbeck, 972 F.2d 1283 (Fed. Cir. 1992) (exclusive forum concerns under USPTO review statutes)
- Interstate Commerce Commission v. Brotherhood of Locomotive Engineers, 482 U.S. 270 (U.S. 1987) (timeliness and tolling principles for agency review actions)